ActivX Biosciences, Inc.   Report issue

For profit Phase 2
Founded: La Jolla CA United States (2000)
Status: Acquired by Kyorin Pharma (2004)

Organization Overview

First Clinical Trial
2007
NCT00525330
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

krp-104 (2 trials)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2